We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's How United Natural (UNFI) Looks Ahead of Q1 Earnings
Read MoreHide Full Article
United Natural Foods, Inc. (UNFI - Free Report) is likely to post an increase in the top and the bottom line when it reports first-quarter fiscal 2021 results on Dec 9. Although the Zacks Consensus Estimate for fiscal first-quarter earnings has moved down 8.8% in the past 30 days to 73 cents per share, it suggests a significant growth from the year-ago quarter’s reported figure. This provider of natural, organic and specialty food as well as non-food products has a trailing four-quarter earnings surprise of 4.8%, on average. In the last reported quarter, the company reported an earnings surprise of 49.3%.
The consensus mark for fiscal first-quarter revenues is pegged at $6.81 billion that indicates growth of 13.1% from the figure reported in the year-ago quarter.
United Natural is witnessing increased consumer demand stemming from coronavirus-induced higher at-home consumption. Moreover, the company is gaining from cross selling efforts. Apart from these, United Natural’s lucrative acquisitions are yielding. Also, its focus on strategic growth efforts such as enhancing customer base and profitability is noteworthy.
However, United Natural is seeing escalated costs to maintain additional safety, health and welfare of its associates amid the pandemic. Moreover, lower demand for away from home services amid coronavirus is a concern.
What the Zacks Model Unveils
Our proven model doesn’t conclusively predict an earnings beat for United Natural this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
United Natural sports a Zacks Rank #1 and an Earnings ESP of -7.17%.
Stocks With Favorable Combinations
Here are some companies that you may want to consider as our model shows that these also have the right combination of elements to post an earnings beat.
McCormick & Company (MKC - Free Report) currently has an Earnings ESP of +1.11% and carries a Zacks Rank #3.
Church & Dwight (CHD - Free Report) currently has an Earnings ESP of +0.95% and a Zacks Rank of 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Here's How United Natural (UNFI) Looks Ahead of Q1 Earnings
United Natural Foods, Inc. (UNFI - Free Report) is likely to post an increase in the top and the bottom line when it reports first-quarter fiscal 2021 results on Dec 9. Although the Zacks Consensus Estimate for fiscal first-quarter earnings has moved down 8.8% in the past 30 days to 73 cents per share, it suggests a significant growth from the year-ago quarter’s reported figure. This provider of natural, organic and specialty food as well as non-food products has a trailing four-quarter earnings surprise of 4.8%, on average. In the last reported quarter, the company reported an earnings surprise of 49.3%.
The consensus mark for fiscal first-quarter revenues is pegged at $6.81 billion that indicates growth of 13.1% from the figure reported in the year-ago quarter.
United Natural Foods, Inc. Price and EPS Surprise
United Natural Foods, Inc. price-eps-surprise | United Natural Foods, Inc. Quote
Factors to Note
United Natural is witnessing increased consumer demand stemming from coronavirus-induced higher at-home consumption. Moreover, the company is gaining from cross selling efforts. Apart from these, United Natural’s lucrative acquisitions are yielding. Also, its focus on strategic growth efforts such as enhancing customer base and profitability is noteworthy.
However, United Natural is seeing escalated costs to maintain additional safety, health and welfare of its associates amid the pandemic. Moreover, lower demand for away from home services amid coronavirus is a concern.
What the Zacks Model Unveils
Our proven model doesn’t conclusively predict an earnings beat for United Natural this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
United Natural sports a Zacks Rank #1 and an Earnings ESP of -7.17%.
Stocks With Favorable Combinations
Here are some companies that you may want to consider as our model shows that these also have the right combination of elements to post an earnings beat.
The Kraft Heinz Company (KHC - Free Report) currently has an Earnings ESP of +3.40% and carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
McCormick & Company (MKC - Free Report) currently has an Earnings ESP of +1.11% and carries a Zacks Rank #3.
Church & Dwight (CHD - Free Report) currently has an Earnings ESP of +0.95% and a Zacks Rank of 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>